Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April

Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April

Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April

Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April

Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April

Sabin Begins Marburg Vaccine Clinical Trial in U.S. Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S. WASHINGTON, April